Literature DB >> 16217102

Inconclusive evidence puts Adderall back on the market.

Wayne Kondro.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16217102      PMCID： PMC1247691          DOI： 10.1503/cmaj.051145

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  2 in total

1.  Questions about Adderall XR.

Authors:  Pierre Biron; Barbara Mintzes; Joel Lexchin
Journal:  CMAJ       Date:  2006-04-25       Impact factor: 8.262

2.  Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults.

Authors:  Xavier Castells; Lídia Blanco-Silvente; Ruth Cunill
Journal:  Cochrane Database Syst Rev       Date:  2018-08-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.